Mettler Toledo (MTD) Q1 2025 10-Q Quarterly Report

Filed: May 2, 2025Period ending Mar 31, 2025
Health Care
Laboratory Analytical InstrumentsSEC EDGAR

Mettler Toledo (MTD) 10-Q quarterly report for Q1 2025, filed with SEC EDGAR on May 2, 2025 for the fiscal period ending Mar 31, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

Mettler Toledo Q1 2025 10-Q Analysis

Risk Factors

  • New risk: Negative gross margin impact expected from escalation in global trade disputes/tariffs in 2025, mitigated by ongoing company actions
  • Updated operational risk: Recovery of prior-year shipping delays reduced current quarter sales growth by up to 12% in key regions, impacting near-term revenue
  • Regulatory/legal risk: Inflation Reduction Act excise tax of $2.0 million in Q1 2025, reducing shareholders' equity compared to $2.1 million in prior year quarter
  • Financial risk: Currency exchange impacts with 1% Swiss franc strengthening reducing annual earnings before tax by $2.4-$2.7 million, plus $47.6 million debt value rise from 5% USD weakening
  • Liquidity risk: $679.8 million available under $1.35 billion Credit Agreement and $64.3 million cash, supporting funding of working capital, share repurchases, and acquisitions

Mettler Toledo Q1 2025 Quarterly Financials
XBRL

Revenue

$884M

Net Income

$164M

Net Margin

18.5%

Source: XBRL data from Mettler Toledo Q1 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other Mettler Toledo Quarterly Reports

Get deeper insights on Mettler Toledo

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.